[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
April 29, 1961

Government Services

JAMA. 1961;176(4):381. doi:10.1001/jama.1961.03040170127020

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.



Research in Pulmonary Diseases.—  The Veterans Administration is broadening its large-scale medical research in cooperation with the Armed Forces to recognize the decline of tuberculosis and the growing importance of other pulmonary conditions. This research program has tested the antituberculosis drugs for the entire medical profession since 1946 and has been known as the VA—Armed Forces Cooperative Studies on the Chemotherapy of Tuberculosis. Henceforth, the annual meeting which this group has conducted will be known as the Research Conference in Pulmonary Diseases of the Veterans Administration and Armed Forces.Dr. William B. Tucker, director of the VA pulmonary disease service in Washington, D.C., said that in recent years, despite substantial decreases in mortality from tuberculosis and certain other respiratory diseases, there have been substantial increases in mortality from pneumonia, emphysema, and cancer of the respiratory system. Respiratory diseases are now the leading cause of disability and the fourth

First Page Preview View Large
First page PDF preview
First page PDF preview